A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization

Cancer Detection and Prevention

Volumn 31, Issue 2, 2007, Pages 154-160

  Dvorchik, Igor ^a   Carr, Brian I ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Breslow test; Esophageal varices; Hazard ratio; Hepatitis B; Hepatitis C; Hepatocellular Carcinoma; Kaplan Meier test; Kruskal Wallis one way analysis variance; Multivariate analysis; Portal vein thrombus; Prognostics; Survival; Tumor vascularity; Unresectable

Indexed keywords

BILIRUBIN;

ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DEMOGRAPHY; FATALITY; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TUMOR BIOPSY;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34247594259     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.02.003     Document Type: Article

References (37)

1. Okuda K., Ohtsuki T., Obeta H., Tomimatsu M., Okazaki N., Hasegawa H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 59 (1985) 918-928
2. Cancer of the Liver Italian Program Investigators. The Cancer of the Liver Italian Program (CLIP) investigators: a new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28 (1998) 751-755
3. Cancer of the Liver Italian Program Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma, the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 31 (2000) 840-845
4. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
5. Sala A., Forner A., Varela M., and Bruix J. Prognostic prediction in patients with hepatocellular carcinoma. Semin Liver Dis 25 (2005) 171-180
6. Leung T.W., Tang A.M., Zee B., Lau W.Y., Lai P.B., Leung K.L., et al. Construction of the Chinese University Prognostic Indices for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94 (2002) 1760-1769
7. Tateishi R., Yoshida H., Shiina S., Imamura H., Hasegawa K., Teratani T., et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 54 (2005) 419-425
8. Chevret S., Trinchet J.C., Mathieu D., Rached A.A., Beaugrand M., and Chastang C. New prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 31 (1999) 133-141
9. Ley I., and Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50 (2002) 681-685
10. Ueno S., Tanabe G., Sako K., Hiwaki T., Hokotate H., Fukukura Y., et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 34 (2001) 529-534
11. Higashino K., Hashinotsume M., Kang K.Y., Takahashi Y., and Yamamura Y. Studies on a variant alkaline phosphatase in sera of patients with hepatocellular carcinoma. Clin Chim Acta 40 (1972) 67-81
12. Higashino K., Kudo S., Otani R., and Yamamura Y. A hepatoma-associated alkaline phosphatase, the Kasahara isozyme, compared with one of the isozymes of FL amnion cells. Ann NY Acad Sci 259 (1975) 337-346
13. Kovalszky I., Kralovanszky J., Jeney A., Lapis K., Karacsonyi S., and Szecheny A. Alkaline phosphatase activity in human and rat liver tumors. Oncology 48 (1991) 144-148
14. Tokiwa T., Endo A., and Sato J. Alkaline phosphatase expression in human cell lines derived from primary hepatomas. Exp Cell Biol 57 (1989) 324-329
15. Chen M.F., Tsai H.P., Jeng L.B., Lee W.C., Yeh C.N., Yu M.C., et al. Prognostic factors after resection for hepatocellular carcinoma in non-cirrhotic livers: univariate and multivariate analysis. World J Surg 27 (2003) 443-447
16. Khan K.N., Tsutsumi T., Nakata K., Nakao K., Kato Y., and Nagataki S. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids. J Gastroenterol Hepatol 13 (1998) 643-650
17. Wolf P.L. Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphatase-lipoprotein-X complex, and intestinal variant alkaline phosphatase. J Clin Lab Anal 8 (1994) 172-176
18. Yaswen P., Thompson N.L., and Fausto N. Oncodevelopmental expression of rat placental alkaline phosphatase. Detection in oval cells during liver carcinogenesis. Am J Pathol 121 (1985) 505-513
19. Xiao M.B., Yao D.F., Zhang H., Qiang H., Huang J.F., Wei Q., et al. Expression and kinetic changes of alkaline phosphatase and its isoenzymes in experimental rat hepatoma. World J Gastroenterol 4 (1998) 323-325
20. Bell H., Jahnsen J., Kittang E., Raknerud N., and Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 39 (2004) 858-863
21. Chen G.Q., Zhang Q., Xu Y.F., Zhang W.Z., Guan M., Su B., et al. Changes of alkaline phosphatase sugar chains in hepatocellular carcinoma tissue. Zhonghua Gan Zang Bing Za Zhi 11 (2003) 739-741 [In Chinese]
22. Narayanan S. Alkaline phosphatase as tumor marker. Ann Clin Lab Sci 132 (1983) 133-136
23. Velazquez R.F., Rodriguez M., Navascues C.A., Linares A., Perez R., Sotorrios N.G., et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37 (2003) 520-527
24. Yeh C.N., Chen M.F., Lee W.C., and Jeng L.B. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81 (2002) 195-202
25. Lerose R., Molinari R., Rocchi E., Manenti F., and Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 37 (2001) 239-245
26. Ychou M., Veyrac M., Hanslik B., Abouhafss M., Daures J.P., Perney P., et al. Prognostic factors of hepatocellular carcinoma: a multivariate analysis in 113 patients. Bull Cancer 82 (1995) 971-974
27. Bukofzer S., Kew M.C., and Rowe P. The prevalence of variant alkaline phosphatases in hepatocellular carcinoma in southern African blacks. Cancer 62 (1988) 978-981
28. Sorimachi K., and Yasumura Y. Regulation of alkaline phosphatase activity in rat hepatoma cells: effects of serum proteins, cycloheximide, actinomycin D, chloroquine, dinitrophenol and potassium cyanide. Biochem Biophys Acta 885 (1986) 272-281
29. Farinati F., Varnier M., Piccoli A., Caldironi M.W., Zotti S., Plebani M., et al. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer. J Med 175 (1986) 347-355
30. Nishimura H., Harada T., Nawata J., Hayakawa M., Nishioka M., Takemoto T., et al. Relation of serum alkaline phosphatase to liver scintigram in patients with hepatocellular carcinoma. Hepatogastroenterology 29 (1982) 249-251
31. Castaldo G., Oriani G., Lofrano M.M., Cimino L., Topa M., Budillon G., et al. Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes. Clin Chem 42 (1996) 1263-1269
32. Castaldo G., Intrieri M., Castellano L., de Sio I., Blanco C.D.V., Sacchetti L., et al. Serum gamma-glutamyltransferase isoform complexed to LDL in diagnosis of small hepatocellular carcinoma. Clin Chem 45 (1999) 1100-1102
33. Sawabu N., Wakabayashi T., Ozaki K., Toya D., Yoneshima M., Kidani H., et al. Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein low or negative patients. Gastroenterol Jpn 20 (1985) 209-210
34. Higashino K., Otani R., Kudo S., Hashinostume M., and Hada T. Hepatocellular carcinoma and a variant alkaline phosphatase. Ann Intern Med 83 (1975) 74-78
35. Higashino K., Kudo S., Yamamura Y., Honda T., and Sakurai J. Possible identity between the hepatoma alkaline phosphatase and an isozyme of human amniotic membrane (FL cells). Clin Chim Acta 60 (1975) 267-272
36. Kim U.B., Doo C.J., Baek S.H., Kim J.H., Lee H.B., Park S.K., et al. Natural history and prognostic factors of primary hepatocellular carcinoma: study of 70 untreated patients. Korean J Intern Med 4 (1989) 136-141
37. Shijo H., and Okazaki M. Prediction of portal vein invasion by hepatocellular carcinoma: correlations between portal vein tumor thrombus and biochemical tests. Jpn J Clin Oncol 21 (1991) 94-99